About the Authors

Joe Zhang

joe.zhang@imperial.ac.uk (JZ); sara.eapen@gmail.com (SE); s.budhdeo@ucl.ac.uk (SB)

Affiliations Instititute of Global Health Innovation, Imperial College London, London, United Kingdom, Department of Critical Care, King’s College Hospital, London, United Kingdom

Joshua Symons

Affiliation Genomics England, London, United Kingdom

Paul Agapow

Affiliation AstraZeneca, Cambridge, United Kingdom

James T. Teo

Affiliations Department of Neurology, King’s College Hospital, London, United Kingdom, London Medical Imaging & AI Centre, Guy’s and St. Thomas’ Hospital, London, United Kingdom

Claire A. Paxton

Affiliation Verana Health, San Francisco, United States of America

Jordan Abdi

Affiliation Holmusk, London, United Kingdom

Heather Mattie

Affiliation Harvard T H Chan School of Public Health, Harvard University, Cambridge, United States of America

Charlie Davie

Affiliations Department of Neurology, Royal Free Hospital, London, United Kingdom, UCLPartners, London, United Kingdom, DATA-CAN UK Health Data Research Hub for Cancer, London, United Kingdom

Aracelis Z. Torres

Affiliation Verana Health, San Francisco, United States of America

Amos Folarin

Affiliation Maudsley Biomedical Research Centre, King’s College London, London, United Kingdom

Harpreet Sood

Affiliation Health Education England, London, United Kingdom

Leo A. Celi

Affiliations Harvard T H Chan School of Public Health, Harvard University, Cambridge, United States of America, Institute for Medical Engineering & Science, Massachusetts Institute of Technology, Cambridge, United States of America

John Halamka

Affiliation Mayo Clinic, Rochester, United States of America

Sara Eapen

joe.zhang@imperial.ac.uk (JZ); sara.eapen@gmail.com (SE); s.budhdeo@ucl.ac.uk (SB)

Affiliation Valo Health, Boston, United States of America

Sanjay Budhdeo

joe.zhang@imperial.ac.uk (JZ); sara.eapen@gmail.com (SE); s.budhdeo@ucl.ac.uk (SB)

Affiliations Department of Neurology, National Hospital for Neurology and Neurosurgery, London, United Kingdom, Department of Clinical and Movement Neurosciences, University College London, London, United Kingdom, School of Biomedical Engineering and Imaging Sciences, King’s College London, London, United Kingdom

Competing Interests

In accordance with the journal’s policy, the authors of this manuscript have the following competing interests to declare: CD has received an honorarium for work with Merck. JTT has previously received research grant support from Innovate UK, NHSX, Office of Life Sciences, Bristol-Meyers-Squibb and Pfizer; has received honorarium from Bayer, Bristol-Meyers-Squibb and Goldman Sachs; holds stock in Amazon, Alphabet, Nvidia, Glaxo Smith Kline; and receives royalties from Wiley-Blackwell Publishing. SB holds equity in Owkin. SB was formerly employed by Boston Consulting Group and Owkin. JZ receives funding from the Wellcome Trust (203928/Z/16/Z) and acknowledges support from the National Institute for Health Research (NIHR) Biomedical Research Centre based at Imperial College NHS Trust and Imperial College London. SB receives funding from the Wellcome Trust (566701). LAC receives funding from the National Institute of Health (NIBIB R01 EB017205). Listed bodies had no role in funding this study, and views expressed are authors’ own.